Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-500,800
Closed -$12.1M 185
2025
Q2
$12.1M Buy
+500,800
New +$11.7M 0.26% 73
2025
Q1
Sell
-834,100
Closed -$22.1M 200
2024
Q4
$22.1M Buy
+834,100
New +$22.6M 0.38% 53
2024
Q3
Sell
-437,700
Closed -$12.2M 177
2024
Q2
$12.2M Buy
+437,700
New +$12.1M 0.23% 71

Other funds holding PFE

Zimmer Partners's PFE Position: Q3 2025 in Review

Zimmer Partners sold out of Pfizer (PFE) in Q3 2025, closing a stake of 500,800 shares — an estimated $12.1M sold.

Zimmer Partners first reported a position in PFE in Q2 2024 and held it in 3 quarters. The position peaked at $22.1M in Q4 2024. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Zimmer Partners reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Zimmer Partners sold 500,800 Pfizer shares in Q3 2025, an estimated $12.1M.
  • Zimmer Partners first reported a position in Pfizer in Q2 2024 and held it in 3 quarters.
  • Zimmer Partners's Pfizer position peaked at $22.1M in Q4 2024.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Zimmer Partners's 13F filing for Q3 2025, filed 14 Nov 2025.